Related content

A functional magnetic resonance imaging study of patients with secondary progressive multiple sclerosis

By Rocca M.A.   Gavazzi C.   Mezzapesa D.M.   Falini A.   Colombo B.   Mascalchi M.   Scotti G.   Comi G.   Filippi M.  

NeuroImage, Vol. 19, Iss. 4, 2003-08 ,pp. : 1770-1777

Elsevier

Access to resources Recommend Favorite

Intrathecal production of Chlamydia pneumoniae-specific high-affinity antibodies is significantly associated to a subset of multiple sclerosis patients with progressive forms

By Fainardi E.   Castellazzi M.   Casetta I.   Cultrera R.   Vaghi L.   Granieri E.   Contini C.  

Journal of the Neurological Sciences, Vol. 217, Iss. 2, 2004-02 ,pp. : 181-188

Elsevier

Access to resources Recommend Favorite

A representative cohort of patients with non-progressive multiple sclerosis at the age of normal life expectancy

By Skoog Bengt  

Brain, Vol. 135, Iss. 3, 2012-04 ,pp. : 900-911

Oxford University Press

Access to resources Recommend Favorite

Treatment of active secondary progressive multiple sclerosis with treosulfan

By Wiendl H.   Kieseier B.   Weissert R.   Mylius H.   Pichlmeier U.   Hartung H.-P.   Melms A.   Kuker W.   Weller M.  

Journal of Neurology, Vol. 254, Iss. 7, 2007-07 ,pp. : 884-889

Springer Publishing Company

Access to resources Recommend Favorite

Immunological profile of patients with primary progressive multiple sclerosis

By Durán I.   Martínez-Cáceres E. M.   Río J.   Barberà N.   Marzo M. E.  

Brain, Vol. 122, Iss. 12, 1999-12 ,pp. : 2297-2307

Oxford University Press

Access to resources Recommend Favorite